DEFINITIVE PROXY STATEMENT

Company

UNITED THERAPEUTICS Corp

Filed

August 19, 2021

Period of Report

September 30, 2021

Accession Number

0001206774-21-002244

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →